Michael W. Boyer
About Michael W. Boyer
Chief Medical Officer
Michael W. Boyer holds the position of Chief Medical Officer. His role involves overseeing the company's medical operations and ensuring that medical practices and procedures align with organizational goals. As Chief Medical Officer, Boyer is responsible for strategic leadership in the development and implementation of clinical practices and policies.
Principal Investigator for Novartis CAR T-cell Team
Michael W. Boyer was the Principal Investigator and a member of the CAR T-cell team at Novartis. His work with CAR T-cell therapies involves cutting-edge research and development in immuno-oncology, focusing on leveraging the body's immune system to target and eliminate cancer cells. Boyer's contributions in this capacity advanced the understanding and application of CAR T-cell therapies.
Director of University of Utah Blood and Marrow Transplant Program
Michael W. Boyer served as the Director of the Blood and Marrow Transplant Program at the University of Utah. In this role, Boyer led the program's efforts to provide advanced treatment options for patients requiring hematopoietic stem cell transplants. His responsibilities included overseeing clinical operations, guiding scientific research, and improving patient care outcomes.
Medical Director for University of Utah Cell Therapy Facility
Michael W. Boyer held the position of Medical Director at the University of Utah Cell Therapy Facility. His role involved overseeing the facility's operations, ensuring the quality and efficacy of cell therapy treatments. As Medical Director, Boyer was instrumental in advancing the facility's research and treatment capabilities in cell and gene therapy.